These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11844259)

  • 1. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes.
    Suarez JI; Zaidat OO; Sunshine JL; Tarr R; Selman WR; Landis DM
    Neurosurgery; 2002 Feb; 50(2):251-9; discussion 259-60. PubMed ID: 11844259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.
    Lee KY; Kim DI; Kim SH; Lee SI; Chung HW; Shim YW; Kim SM; Heo JH
    AJNR Am J Neuroradiol; 2004 Oct; 25(9):1470-5. PubMed ID: 15502123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
    Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
    Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke.
    Qureshi AI; Siddiqui AM; Kim SH; Hanel RA; Xavier AR; Kirmani JF; Suri MF; Boulos AS; Hopkins LN
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):322-8. PubMed ID: 14970040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset.
    Derex L; Tomsick TA; Brott TG; Lewandowski CA; Frankel MR; Clark W; Starkman S; Spilker J; Udsten GJ; Khoury J; Grotta JC; Broderick JP;
    AJNR Am J Neuroradiol; 2001 Apr; 22(4):685-90. PubMed ID: 11290479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke.
    Qureshi AI; Ali Z; Suri MF; Kim SH; Shatla AA; Ringer AJ; Lopes DK; Guterman LR; Hopkins LN
    Neurosurgery; 2001 Jul; 49(1):41-8; discussion 48-50. PubMed ID: 11440458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years.
    Kim D; Ford GA; Kidwell CS; Starkman S; Vinuela F; Duckwiler GR; Jahan R; Saver JL;
    AJNR Am J Neuroradiol; 2007 Jan; 28(1):159-63. PubMed ID: 17213448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):1033-1040. PubMed ID: 29221968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study.
    Qureshi AI; Siddiqui AM; Suri MF; Kim SH; Ali Z; Yahia AM; Lopes DK; Boulos AS; Ringer AJ; Saad M; Guterman LR; Hopkins LN
    Neurosurgery; 2002 Nov; 51(5):1319-27; discussion 1327-9. PubMed ID: 12383381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
    Alexandrov AV; Wojner AW; Grotta JC;
    J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial.
    Alexandrov AV; Demchuk AM; Burgin WS; Robinson DJ; Grotta JC;
    J Neuroimaging; 2004 Apr; 14(2):113-7. PubMed ID: 15095555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.